ABL Bio Inc. (KOSDAQ:298380)
35,250
-2,600 (-6.87%)
Nov 20, 2026, 3:30 PM KST
| Market Cap | 1.97T -78.9% |
| Revenue (ttm) | 34.28B -63.9% |
| Net Income | -78.63B |
| EPS | -1,424.79 |
| Shares Out | 55.99M |
| PE Ratio | n/a |
| Forward PE | n/a |
| Dividend | n/a |
| Ex-Dividend Date | n/a |
| Volume | 269,209 |
| Open | 36,500 |
| Previous Close | 37,850 |
| Day's Range | 34,900 - 37,200 |
| 52-Week Range | 33,900 - 257,500 |
| Beta | 0.35 |
| Analysts | Buy |
| Price Target | 270,000.00 (+665.96%) |
| Est. Earnings | Nov 24, 2026 |